BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegaert K, Mekahli D, van den Anker J. Cystatin C in newborns: a promising renal biomarker in search for standardization and validation. J Matern Fetal Neonatal Med 2015;28:1833-8. [PMID: 25260126 DOI: 10.3109/14767058.2014.969236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 He Z, Fang Y, Zuo Q, Huang X, Lei Y, Ren X, Liu D. Vertical transmission and kidney damage in newborns whose mothers had coronavirus disease 2019 during pregnancy. Int J Antimicrob Agents 2021;57:106260. [PMID: 33309765 DOI: 10.1016/j.ijantimicag.2020.106260] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
2 van Donge T, Welzel T, Atkinson A, van den Anker J, Pfister M. Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics. J Clin Pharmacol 2019;59 Suppl 1:S21-32. [PMID: 31502686 DOI: 10.1002/jcph.1487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Dyson A, Kent AL. Diagnosis of Acute Kidney Injury in Neonates: Can Urinary Biomarkers Help? Curr Treat Options Peds 2018;4:425-37. [DOI: 10.1007/s40746-018-0141-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 den Bakker E, Gemke RJBJ, Bökenkamp A. Endogenous markers for kidney function in children: a review. Critical Reviews in Clinical Laboratory Sciences 2018;55:163-83. [DOI: 10.1080/10408363.2018.1427041] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
5 Muhari-Stark E, Burckart GJ. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use. J Pediatr Pharmacol Ther 2018;23:424-31. [PMID: 30697127 DOI: 10.5863/1551-6776-23.6.424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tong C, Liu Y, Wu Y, Li Q, Wu Y, Wang L, Chen Y. Gestational and Age-Specific Cystatin C Reference Intervals for Newborns. Am J Perinatol 2021. [PMID: 33621984 DOI: 10.1055/s-0041-1724000] [Reference Citation Analysis]
7 Borloo N, Smits A, Thewissen L, Annaert P, Allegaert K. Creatinine Trends and Patterns in Neonates Undergoing Whole Body Hypothermia: A Systematic Review. Children (Basel) 2021;8:475. [PMID: 34200017 DOI: 10.3390/children8060475] [Reference Citation Analysis]
8 Kastl JT. Renal function in the fetus and neonate - the creatinine enigma. Semin Fetal Neonatal Med 2017;22:83-9. [PMID: 28109705 DOI: 10.1016/j.siny.2016.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
9 Samardzic J, Turner MA, Bax R, Allegaert K. Neonatal medicines research: challenges and opportunities. Expert Opin Drug Metab Toxicol 2015;11:1041-52. [PMID: 25958820 DOI: 10.1517/17425255.2015.1046433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
10 Li Y, Dammer EB, Zhang-Brotzge X, Chen S, Duong DM, Seyfried NT, Kuan CY, Sun YY. Osteopontin Is a Blood Biomarker for Microglial Activation and Brain Injury in Experimental Hypoxic-Ischemic Encephalopathy. eNeuro 2017;4:ENEURO. [PMID: 28101531 DOI: 10.1523/ENEURO.0253-16.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
11 Wilbaux M, Fuchs A, Samardzic J, Rodieux F, Csajka C, Allegaert K, van den Anker JN, Pfister M. Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates. J Clin Pharmacol 2016;56:909-35. [PMID: 26766774 DOI: 10.1002/jcph.705] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
12 Barker CIS, Standing JF, Kelly LE, Hanly Faught L, Needham AC, Rieder MJ, de Wildt SN, Offringa M. Pharmacokinetic studies in children: recommendations for practice and research. Arch Dis Child 2018;103:695-702. [PMID: 29674514 DOI: 10.1136/archdischild-2017-314506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zhang Y, Mehta N, Muhari-Stark E, Burckart GJ, van den Anker J, Wang J. Pediatric Renal Ontogeny and Applications in Drug Development. J Clin Pharmacol 2019;59 Suppl 1:S9-S20. [PMID: 31502684 DOI: 10.1002/jcph.1490] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Kandasamy Y, Rudd D. Cystatin C: A more reliable biomarker of renal function in young infants? A longitudinal cohort study. Acta Paediatr 2021;110:1341-5. [PMID: 32799396 DOI: 10.1111/apa.15538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Allegaert K, Smits A, van Donge T, van den Anker J, Sarafidis K, Levtchenko E, Mekahli D. Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions. Front Pediatr 2020;8:366. [PMID: 32850523 DOI: 10.3389/fped.2020.00366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
16 Girardi A, Raschi E, Galletti S, Allegaert K, Poluzzi E, De Ponti F. Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development. Expert Opin Drug Metab Toxicol 2017;13:555-65. [PMID: 28141945 DOI: 10.1080/17425255.2017.1290081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Leroux S, Biran V, van den Anker J, Gotta V, Zhao W, Zhang D, Jacqz-Aigrain E, Pfister M. Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates. Front Pharmacol 2021;12:634686. [PMID: 33967770 DOI: 10.3389/fphar.2021.634686] [Reference Citation Analysis]